Tempest Therapeutics Inc.

NASDAQ: TPST · Real-Time Price · USD
6.57
-0.22 (-3.24%)
At close: May 14, 2025, 3:55 PM

Tempest Therapeutics Revenue

Tempest Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Tempest Therapeutics generated $486K in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
24
Market Cap
24.01M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.